Hyperosteogeny is a kind of pathogenic hyperplasia grown between the vertebras and

between the joints, which thickens or bony spur the fringe of the vertebra and the joint and

causes the gaps between the vertebras and between the joints to become narrow. As the

hyperplasia will oppress the nerve to produce local aseptic inflammations such as aches,

distending pains, oedema, even muscle fiber adhesion, some patients of serious nerve

oppression may develop actinomorphous numbness of the limbs accompanied with pains.

The pathogenic factors of hyperostosis are quite complicated, and according the medical

coverage, it is considered to have direct relations with the growth of age, degradation of

enzyme activity(degenerative pathological changes), and the uncured obsolete wounds.

Added up to the long-term deficiency of calcium, it is possible to cause the disorder of bone

secretion, inducing the occurrence of hyperostosis. If TDP therapeutic apparatus is used to

control the initial phase of various pains persistently, many patients can have no occurrence

of clinical symptom within months of years. Welcome to try TDP therapeutic apparatus, my

 patient friends.

I. Therapeutic time:

  The treatment of hyperosteogeny should be conducted preferably at the initial phase when

any damage is discovered to the joints. At this stage, it will be feasible to get the symptom

effectively controlled by way of treatment at a frequency of 1hour a day for 3-5days. When

spurs or marginal hyperplasy appears, in addition to proper rest, the treatment must be

carried out three times a day and above 1hour each time for at least half a year before the

disease is actually controlled.

II. Therapeutic Method

  Aim TDP therapeutic apparatus head at and irradiate diseased part. Application time and

times shall be adjusted according to the symptom phases described above, in case the low-

emperature soft therapeutic apparatus head is applied, the time can be lengthened to hours or

 whole-night treatment may be applied.